Prices delayed by at least 15 minutes | Print

Live UK pricing:

Shield Therapeutics PLC (STX)

ORD 1.5P
Sell: 5.70p|Buy: 5.90p|Change: 0.06 (1.03%)

Open 

5.80p


Previous close 

5.80p


Trade high 

5.90p


Volume 

42,829


Year high 

12.50p


Year low 

2.30p


Dividend yield 


Market capitalisation 

£62.67 mn


P/E ratio 

32.15


ISIN 

GB00BYV81293


Share price

Performance 04/06/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Shield Therapeutics PLC+ 0.87
More...

Company profile

Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company that delivers ACCRUFeR/FeRACCRU (ferric maltol), a differentiated pharmaceutical product, to address the unmet need for patients suffering from iron deficiency,with or without anemia. The company has launched ACCRUFeR in the U.S. Outside of the U.S., it has licensed the rights to specialty pharmaceutical companies. FeRACCRU is commercialised in the UK, the European Union, and Canada, with marketing rights in Australia and New Zealand. The company's operating segments are: FeRACCRU, which generates the maximum revenue, and PT20. Geographically, it generates maximum revenue from the U.S., and the rest from the Netherlands, Canada, Japan, and South Korea.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
05/06/202608:02:385.864,257249.46
05/06/202608:00:335.8620,0001,172.00
05/06/202608:00:305.759,939571.49
05/06/202608:00:005.98,633509.35
04/06/202604:24:585.93,404200.84

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.